Abstract
Development of Positron-Emission-Tomography (PET) dates back to mid 70's albeit this imaging procedure gained its diagnostic importance not before 1990. Meanwhile, a lot of inventions occurred dealing with the software of the Positron-Emission-Tomographs as a necessity to cover the lack of detailed anatomy in the emission data. PET-CT systems have been manufactured and the edited fusion hybrid PET/CT morpho-metabolic images provide excellent high resolution stereotactic anatomical information. The high popularity of PET/CT worldwide led to an improved situation regarding its cost reimbursement. Under this aspect the Greek Government and the Health Care System accepted, after a well documented medical report by the ordering physician, to cover the cost of PET/CT examination with 900 Euro for the procedure plus the cost of any radiopharmaceutical used (i.e. F-18 DG etc). Eleven concessions of PET/CT expediencies, 7 construction approvals and 4 PET/CT running licenses have been issued up to September 2007. A 16.5 MeV GE PETtrace cyclotron has been installed at Lavrion area, about 40km along the city of Athens, the Greek capital. In the year 2004 it has started providing positron emitting radiopharmaceuticals in limited quantities and for the time being only F1 8-DG is distributed. So far, Fl 8-DG is exclusively
More>>
Limouris, G S;
Lyra, M;
Stavrak, A;
[1]
Kamenopoulou, V;
Vogiatzi, S
[2]
- Nuclear Medicine Dept, 'Aretaieion' Univ Hosp, Athens Medical School (Greece)
- Greek Atomic Energy Comission (Greece)
Citation Formats
Limouris, G S, Lyra, M, Stavrak, A, Kamenopoulou, V, and Vogiatzi, S.
A window on Greece (experience, present state of PET/CT scan facilities and reimbursement policy).
IAEA: N. p.,
2007.
Web.
Limouris, G S, Lyra, M, Stavrak, A, Kamenopoulou, V, & Vogiatzi, S.
A window on Greece (experience, present state of PET/CT scan facilities and reimbursement policy).
IAEA.
Limouris, G S, Lyra, M, Stavrak, A, Kamenopoulou, V, and Vogiatzi, S.
2007.
"A window on Greece (experience, present state of PET/CT scan facilities and reimbursement policy)."
IAEA.
@misc{etde_20997245,
title = {A window on Greece (experience, present state of PET/CT scan facilities and reimbursement policy)}
author = {Limouris, G S, Lyra, M, Stavrak, A, Kamenopoulou, V, and Vogiatzi, S}
abstractNote = {Development of Positron-Emission-Tomography (PET) dates back to mid 70's albeit this imaging procedure gained its diagnostic importance not before 1990. Meanwhile, a lot of inventions occurred dealing with the software of the Positron-Emission-Tomographs as a necessity to cover the lack of detailed anatomy in the emission data. PET-CT systems have been manufactured and the edited fusion hybrid PET/CT morpho-metabolic images provide excellent high resolution stereotactic anatomical information. The high popularity of PET/CT worldwide led to an improved situation regarding its cost reimbursement. Under this aspect the Greek Government and the Health Care System accepted, after a well documented medical report by the ordering physician, to cover the cost of PET/CT examination with 900 Euro for the procedure plus the cost of any radiopharmaceutical used (i.e. F-18 DG etc). Eleven concessions of PET/CT expediencies, 7 construction approvals and 4 PET/CT running licenses have been issued up to September 2007. A 16.5 MeV GE PETtrace cyclotron has been installed at Lavrion area, about 40km along the city of Athens, the Greek capital. In the year 2004 it has started providing positron emitting radiopharmaceuticals in limited quantities and for the time being only F1 8-DG is distributed. So far, Fl 8-DG is exclusively used for tumor imaging and mapping. Four PET/CT facilities for medical diagnosis are operated in Greece, up to now. The profile of the PET/CT doses/studies conducted per year as long as this report is shown in the figures. (author)}
place = {IAEA}
year = {2007}
month = {Nov}
}
title = {A window on Greece (experience, present state of PET/CT scan facilities and reimbursement policy)}
author = {Limouris, G S, Lyra, M, Stavrak, A, Kamenopoulou, V, and Vogiatzi, S}
abstractNote = {Development of Positron-Emission-Tomography (PET) dates back to mid 70's albeit this imaging procedure gained its diagnostic importance not before 1990. Meanwhile, a lot of inventions occurred dealing with the software of the Positron-Emission-Tomographs as a necessity to cover the lack of detailed anatomy in the emission data. PET-CT systems have been manufactured and the edited fusion hybrid PET/CT morpho-metabolic images provide excellent high resolution stereotactic anatomical information. The high popularity of PET/CT worldwide led to an improved situation regarding its cost reimbursement. Under this aspect the Greek Government and the Health Care System accepted, after a well documented medical report by the ordering physician, to cover the cost of PET/CT examination with 900 Euro for the procedure plus the cost of any radiopharmaceutical used (i.e. F-18 DG etc). Eleven concessions of PET/CT expediencies, 7 construction approvals and 4 PET/CT running licenses have been issued up to September 2007. A 16.5 MeV GE PETtrace cyclotron has been installed at Lavrion area, about 40km along the city of Athens, the Greek capital. In the year 2004 it has started providing positron emitting radiopharmaceuticals in limited quantities and for the time being only F1 8-DG is distributed. So far, Fl 8-DG is exclusively used for tumor imaging and mapping. Four PET/CT facilities for medical diagnosis are operated in Greece, up to now. The profile of the PET/CT doses/studies conducted per year as long as this report is shown in the figures. (author)}
place = {IAEA}
year = {2007}
month = {Nov}
}